{"id":"https://openalex.org/W2103188564","doi":null,"title":"Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.","display_name":"Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-01-15","ids":{"openalex":"https://openalex.org/W2103188564","mag":"2103188564","pmid":"https://pubmed.ncbi.nlm.nih.gov/9927058"},"language":"en","primary_location":{"id":"pmid:9927058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9927058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2103188564"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"I Kawashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273692","display_name":"Takara Shuzo Co., Ltd. (Japan)","ror":"https://ror.org/009xcqz70","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405273692"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"I Kawashima","raw_affiliation_strings":["Takara Shuzo Co., Ltd., Biotechnology Research Laboratories, Otsu, Shiga, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takara Shuzo Co., Ltd., Biotechnology Research Laboratories, Otsu, Shiga, Japan","institution_ids":["https://openalex.org/I4405273692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033339482","display_name":"Van Tsai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Tsai","raw_affiliation_strings":["Epimmune"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epimmune","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041720192","display_name":"Scott Southwood","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Southwood","raw_affiliation_strings":["Epimmune"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epimmune","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007564314","display_name":"Kazutoh Takesako","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273692","display_name":"Takara Shuzo Co., Ltd. (Japan)","ror":"https://ror.org/009xcqz70","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405273692"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"K Takesako","raw_affiliation_strings":["Takara Shuzo Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takara Shuzo Co., Ltd","institution_ids":["https://openalex.org/I4405273692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010966529","display_name":"Alessandro Sette","orcid":"https://orcid.org/0000-0001-7013-2250","observed_orcids":["https://orcid.org/0000-0001-7013-2250"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Sette","raw_affiliation_strings":["Epimmune"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epimmune","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032554768","display_name":"Esteban Celis","orcid":"https://orcid.org/0000-0001-8299-4480","observed_orcids":["https://orcid.org/0000-0001-8299-4480"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E Celis","raw_affiliation_strings":["Mayo Clinic Rochester-MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic Rochester-MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.9089,"has_fulltext":false,"cited_by_count":140,"citation_normalized_percentile":{"value":0.96284974,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"59","issue":"2","first_page":"431","last_page":"435"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hla-a3","display_name":"HLA-A3","score":0.8299999833106995},{"id":"https://openalex.org/keywords/ctl-epitopes","display_name":"CTL epitopes","score":0.8629999756813049},{"id":"https://openalex.org/keywords/carcinoembryonic-antigen","display_name":"carcinoembryonic antigen","score":0.9959999918937683},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9929999709129333},{"id":"https://openalex.org/keywords/peptide-pulsed-dendritic-cells","display_name":"peptide-pulsed dendritic cells","score":0.8489999771118164},{"id":"https://openalex.org/keywords/mhc-binding","display_name":"MHC binding","score":0.6539999842643738},{"id":"https://openalex.org/keywords/tumor-associated-antigens","display_name":"tumor-associated antigens","score":0.777999997138977}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.8458743095397949},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.8251307010650635},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6142784953117371},{"id":"https://openalex.org/C207936829","wikidata":"https://www.wikidata.org/wiki/Q423163","display_name":"Major histocompatibility complex","level":3,"score":0.6033892035484314},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5446398258209229},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5414862632751465},{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.5328436493873596},{"id":"https://openalex.org/C2777387746","wikidata":"https://www.wikidata.org/wiki/Q769706","display_name":"Carcinoembryonic antigen","level":3,"score":0.47795772552490234},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47415226697921753},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.27901241183280945},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.17033326625823975},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09283456206321716},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.08687406778335571}],"mesh":[{"descriptor_ui":"D002272","descriptor_name":"Carcinoembryonic Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003429","descriptor_name":"Cross Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007114","descriptor_name":"Immunization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015791","descriptor_name":"HLA-A3 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D018984","descriptor_name":"Epitopes, T-Lymphocyte","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:9927058","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9927058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2103188564","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9927058","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G140262634","display_name":"HLA AND VACCINES (BAA)","funder_award_id":"n01ai045241-010","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W51158438","https://openalex.org/W1483529363","https://openalex.org/W1495668897","https://openalex.org/W1509731174","https://openalex.org/W1555916481","https://openalex.org/W1607007957","https://openalex.org/W1967410720","https://openalex.org/W1977876194","https://openalex.org/W1981973325","https://openalex.org/W1986050959","https://openalex.org/W1990395260","https://openalex.org/W2006987944","https://openalex.org/W2017304478","https://openalex.org/W2018544821","https://openalex.org/W2028387622","https://openalex.org/W2030229250","https://openalex.org/W2054037411","https://openalex.org/W2058685264","https://openalex.org/W2069417575","https://openalex.org/W2070154027","https://openalex.org/W2073575430","https://openalex.org/W2090970424","https://openalex.org/W2092229345","https://openalex.org/W2095156669","https://openalex.org/W2095575390","https://openalex.org/W2100137871","https://openalex.org/W2109913659","https://openalex.org/W2113689513","https://openalex.org/W2123679993","https://openalex.org/W2124376809","https://openalex.org/W2124403991","https://openalex.org/W2125913713","https://openalex.org/W2131761283","https://openalex.org/W2133466768","https://openalex.org/W2141393790","https://openalex.org/W2141935247","https://openalex.org/W2142066580","https://openalex.org/W2145136557","https://openalex.org/W2151926043","https://openalex.org/W2159363679","https://openalex.org/W2164331722","https://openalex.org/W2166831581","https://openalex.org/W2167198299"],"related_works":["https://openalex.org/W2112921922","https://openalex.org/W2123506425","https://openalex.org/W2064120965","https://openalex.org/W2095575390","https://openalex.org/W2054274684","https://openalex.org/W1973319481","https://openalex.org/W2024073773","https://openalex.org/W2105584714","https://openalex.org/W2088819465","https://openalex.org/W2018613855"],"abstract_inverted_index":{"The":[0],"human":[1,35],"carcinoembryonic":[2],"antigen":[3],"(CEA)":[4],"and":[5,23,73,82,110,133,156,171],"HER-2/neu":[6,74,83,114],"are":[7],"potential":[8],"target":[9],"antigens":[10],"for":[11,15,47,86],"CTL":[12,27,68,92,121,193],"specific":[13],"immunotherapy":[14],"common":[16,34,60,145],"malignancies":[17],"such":[18],"as":[19],"breast,":[20],"lung,":[21],"colon,":[22],"gastric":[24],"carcinomas.":[25],"Several":[26],"epitopes":[28,56,69,194],"restricted":[29,57],"by":[30,58,88],"HLA-A2,":[31],"the":[32,48,71,134,143,150,172,182,207],"most":[33,144],"histocompatibility":[36,61],"molecule,":[37],"have":[38],"been":[39],"previously":[40],"reported.":[41],"However,":[42],"to":[43,54,119,149,177,179],"develop":[44],"CTL-based":[45],"immunotherapies":[46],"general":[49],"population,":[50],"it":[51],"is":[52],"necessary":[53],"identify":[55],"other":[59,204],"alleles.":[62,185],"Here,":[63],"we":[64],"describe":[65],"two":[66,191],"HLA-A3-restricted":[67],"from":[70,80,100,106,113],"CEA":[72,81,107],"antigens.":[75],"HLA-A3":[76,132,151,208],"binding":[77,140],"synthetic":[78],"peptides":[79],"were":[84,117],"tested":[85],"immunogenicity":[87],"in":[89,198],"vitro":[90],"primary":[91],"induction":[93],"protocol":[94],"using":[95],"peripheral":[96],"blood":[97],"mononuclear":[98],"cells":[99],"normal":[101],"healthy":[102],"volunteers.":[103],"One":[104],"peptide":[105,112],"(CEA[9(61)]:":[108],"HLFGYSWYK)":[109],"one":[111],"(HER2[9(754)]:":[115],"VLRENTSPK)":[116],"shown":[118],"induce":[120],"that":[122,159,189],"was":[123,175],"capable":[124],"of":[125,163,181,206],"killing":[126],"a":[127],"tumor":[128],"cell":[129],"line":[130],"expressing":[131,200],"corresponding":[135],"tumor-associated":[136],"antigen.":[137],"Additional":[138],"MHC":[139],"studies":[141],"with":[142,168],"HLA":[146],"molecules":[147,167],"belonging":[148],"superfamily":[152],"(HLA-A*1101,":[153],"-A*3101,":[154],"-A*3301,":[155],"-A*6801),":[157],"demonstrated":[158],"CEA[9(61)]":[160],"binds":[161],"five":[162,164,184],"A3":[165],"supertype":[166],"high":[169],"affinity,":[170],"HER2[9(754)]":[173],"epitope":[174],"able":[176],"bind":[178],"four":[180],"same":[183],"These":[186],"results":[187],"indicate":[188],"these":[190],"new":[192],"should":[195],"be":[196],"immunogenic":[197],"individuals":[199],"either":[201],"HLA-A3,":[202],"or":[203],"members":[205],"superfamily.":[209]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2103188564","counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
